Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating income | -$8.29M | -$23.4M | -$14.3M | -$16.8M | -$40.2M |
| Net income | -$9.79M | -$18.1M | -$13.2M | $2.78M | -$39.7M |
| EPS (diluted) | -$1.69 | -$2.41 | -$1.07 | $2.63 | -$22.61 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$9.31M | -$17.0M | -$10.8M | -$27.2M | -$28.1M |
| Capital expenditures | $6.04K | $1.98K | — | — | — |
| Free cash flow | -$9.31M | -$17.0M | — | — | — |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $16.9M | $5.88M | $12.6M | $13.3M | $6.12M |
| Total assets | $17.7M | $6.92M | $13.6M | $18.9M | $9.18M |
| Total liabilities | $12.1M | $8.27M | $9.87M | $2.42M | $10.4M |
| Long-term debt | $3.91M | — | $0.00 | — | — |
| Shareholders' equity | $5.66M | -$1.35M | $3.75M | $16.5M | -$1.26M |
| Retained earnings | -$62.2M | -$80.3M | -$93.5M | -$90.7M | -$130M |
| Shares (wtd avg diluted) | 5.79M | 7.50M | 12.3M | 1.06M | 1.76M |
Every figure is extracted from ProMIS Neurosciences Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.